These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18336218)

  • 1. Recent advances in high throughput screening for ADME properties.
    Carlson TJ; Fisher MB
    Comb Chem High Throughput Screen; 2008 Mar; 11(3):258-64. PubMed ID: 18336218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
    Roberts SA
    Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro ADME profiling using high-throughput rapidfire mass spectrometry: cytochrome p450 inhibition and metabolic stability assays.
    Wu X; Wang J; Tan L; Bui J; Gjerstad E; McMillan K; Zhang W
    J Biomol Screen; 2012 Jul; 17(6):761-72. PubMed ID: 22460176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of mass spectrometry for in-vitro ADME assays.
    Chu I; Nomeir AA
    Curr Drug Metab; 2006 Jun; 7(5):467-77. PubMed ID: 16787156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present and future in vitro approaches for drug metabolism.
    Ekins S; Ring BJ; Grace J; McRobie-Belle DJ; Wrighton SA
    J Pharmacol Toxicol Methods; 2000; 44(1):313-24. PubMed ID: 11274898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
    Shou WZ; Zhang J
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probe ADME and test hypotheses: a PATH beyond clearance in vitro-in vivo correlations in early drug discovery.
    Bell LC; Wang J
    Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1131-55. PubMed ID: 22681474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism.
    Ansede JH; Thakker DR
    J Pharm Sci; 2004 Feb; 93(2):239-55. PubMed ID: 14705182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in predicting human ADME parameters in silico.
    Ekins S; Waller CL; Swaan PW; Cruciani G; Wrighton SA; Wikel JH
    J Pharmacol Toxicol Methods; 2000; 44(1):251-72. PubMed ID: 11274894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery.
    Ackermann BL; Berna MJ; Murphy AT
    Curr Top Med Chem; 2002 Jan; 2(1):53-66. PubMed ID: 11899065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of cytochrome P450-mediated drug metabolism.
    Zhang T; Chen Q; Li L; Liu LA; Wei DQ
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):388-95. PubMed ID: 21470181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability.
    Gombar VK; Silver IS; Zhao Z
    Curr Top Med Chem; 2003; 3(11):1205-25. PubMed ID: 12769701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further Considerations Towards an Effective and Efficient Oncology Drug Discovery DMPK Strategy.
    Williamson B; Colclough N; Fretland AJ; Jones BC; Jones RDO; McGinnity DF
    Curr Drug Metab; 2020; 21(2):145-162. PubMed ID: 32164508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
    Yan Z; Caldwell GW
    Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries.
    Jenkins KM; Angeles R; Quintos MT; Xu R; Kassel DB; Rourick RA
    J Pharm Biomed Anal; 2004 Mar; 34(5):989-1004. PubMed ID: 15019033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting RNA structures in diseases with small molecules.
    Shao Y; Zhang QC
    Essays Biochem; 2020 Dec; 64(6):955-966. PubMed ID: 33078198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential pharmacological and toxicological impact of P450 screening.
    Riley RJ
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):45-54. PubMed ID: 11727322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From in vivo to in vitro/in silico ADME: progress and challenges.
    Van de Waterbeemd H
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):1-4. PubMed ID: 16922647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in computational prediction of drug absorption and permeability in drug discovery.
    Hou T; Wang J; Zhang W; Wang W; Xu X
    Curr Med Chem; 2006; 13(22):2653-67. PubMed ID: 17017917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.